| Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma TJ Grant, JA Bishop, LM Christadore, G Barot, HG Chin, S Woodson, ... Proceedings of the National Academy of Sciences 109 (12), 4503-4508, 2012 | 57 | 2012 |
| Chiral amino alcohols via catalytic enantioselective Petasis borono-Mannich reactions J Kavouris, K Kavouris, VM Wambua, R Demerzhan, P Moquist, ... | 6 | 2020 |
| Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics U Hansen, S Schaus, T Grant, J Bishop, J Kavouris, LM Christadore US Patent 9,802,948, 2017 | 4 | 2017 |
| Inhibitors of late SV40 factor (LSF) as cancer chemotherapeutics U Hansen, S Schaus, T Grant, J Bishop, J Kavouris, LM Christadore US Patent 9,815,845, 2017 | 3 | 2017 |
| Discovery of pyrazolopyrrolidinones as potent, broad-spectrum inhibitors of Leishmania infection JA Kavouris, LI McCall, MA Giardini, G De Muylder, D Thomas, ... Frontiers in tropical diseases 3, 1011124, 2023 | 2 | 2023 |
| Mannich reactions and the synthesis of heterocycles as antiproliferative agents in cancer and neglected tropical disease JA Kavouris Boston University, 2020 | 1 | 2020 |
| Antileishmanial compounds, compositions and use thereof SE Schaus, LE Brown, MW Grinstaff, DM Fitzgerald, JA KAVOURIS, ... US Patent App. 18/201,938, 2023 | | 2023 |
| Heterocyclic lsf inhibitors and their uses SE Schaus, U Hansen, JA Kavouris, N POKHAREL US Patent App. 17/559,114, 2022 | | 2022 |
| Antiproliferative small-molecule inhibitors of transcription factor LSF reveal oncogene addiction to LSF in hepatocellular carcinoma (vol 109, pg 4503, 2012) TJ Grant, JA Bishop, LM Christadore, G Barot, HG Chin, S Woodson, ... PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF …, 2022 | | 2022 |
| Heterocyclic LSF inhibitors and their uses SE Schaus, U Hansen, JA Kavouris, N POKHAREL US Patent 11,242,353, 2022 | | 2022 |
| Assessing the sensitivity of LSF inhibitors against liver cancer N Pokharel, J Kavouris, J Biagi, U Hansen, SE Schaus Cancer Research 80 (16), 2020 | | 2020 |
| Inhibitors of Late SV40 Factor (LSF) as cancer chemotherapeutics U Hansen, S Schaus, T Grant, J Bishop, J Kavouris, LM Christadore US Patent 10,392,398, 2019 | | 2019 |
| N-Myristoyltransferase inhibition as a tool for antileishmanial drug discovery: Use in high-throughput, de novo, and piggyback strategies for drug development J Kavouris University of Pittsburgh, 2014 | | 2014 |
